Abstract
Down syndrome (DS) patients overexpress human DS critical region gene 1 (hDSCR-1), whose translational product inhibits calcineurin-dependent signaling pathways of genetic transcription. Compared to hDSCR-1, C. elegans rcn-1 has 40% sequence similarity and its proteins share an analogous function with hDSCR-1 in regulating calcineurin. Taurine has had a positive effect on DS patients. According to animal research studies, taurine reduces the expression of MCIP1, a calcineurin inhibitory protein, on C2C12 myotubes and fibroblast in mouse. This study utilizes two C. elegans models for DS: rcn-1 overexpression model, displaying a calcineurin-deficient phenotype, and calcineurin loss-of function mutants. C. elegans larvae were treated with taurine to characterize its effect and mechanism in helping DS patients. RCN-1 expression and behavioral changes were examined in rcn-1 overexpression and calcineurin-deficient models at different concentrations of taurine. When treated with taurine, transgenic worms harboring an rcn-1 reporter (RCN-1::GFP) showed a reduced level of rcn-1 mRNA expression and improved behaviors that were comparable to those in the wild type. These results indicate that taurine exerts a down-regulating effect on the expression of rcn-1 and, consequently, a positive effect on the expression of calcineurins. In summary, taurine may improve the DS symptoms by prompting a positive interaction between RCN-1 and calcineurin. Furthermore, these results suggest that novel mechanisms may regulate interactions among taurine, RCN-1 and calcineurin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- CnA:
-
Calcineurin A
- DS:
-
Down syndrome
- DSCR-1:
-
Down syndrome critical region 1
- GFP:
-
Green fluorescent protein
- GOF:
-
Gain of function
- LOF:
-
Loss of function
- NGM:
-
Nematode growth medium
- RCN:
-
Regulator of calcineurin
References
Balch PA (2006) Prescription for nutritional healing, 4 edition. Paperback, p 60
Bandyopadhyay J, Lee J, Lee J, Lee JI, Yu JR, Jee C, Cho JH, Jung S, Lee MH, Zannoni S, Singson A, Kim DH, Koo HS, Ahnn J (2002) Calcineurin, a calcium/calmodulin-dependent protein phosphatase, is involved in movement, fertility, egg laying, and growth in Caenorhabditis elegans. Mol Biol Cell 13:3281–3293
De Arcangelis V, Coletti D, Canato M, Molinaro M, Adamo S, Reggiani C, Naro F (2006) Hypertrophy and transcriptional regulation induced in myogenic cell line L6-C5 by an increase of extracellular calcium. J Cell Physiol 202:787–795
Dwivedi M, Song HO, Ahnn J (2009) Autophagy genes mediate the effect of calcineurin on life span in C. elegans. Autophagy 5:604–607
Esbensen AJ (2010) Health conditions associated with aging and end of life of adults with Down syndrome. Int Rev Res Ment Retard 39:107–126
Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, Luna S (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681–1690
Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163
Kaletta T, Hengartner MO (2006) Finding function in novel targets: C. elegans as a model organisms. Nature 5:387–399
Kerai MDJ, Waterfield CJ, Kenyon SH, Asker DS, Timbrell JA (1998) Taurine: protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats. Amino Acids 15:53–76
Klee CB, Crouch TH, Krinks MH (1979) Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A 76:6270–6273
Klee CB, Ren H, Wang X (1998) Regulation of the calmodulin-stimulated protein phosphatase calcineurin. J Biol Chem 273:13367–13370
Kuhara A, Inada H, Katsura I, Mori I (2002) Negative regulation and gain control of sensory neurons by the C. elegans calcineurin tax-6. Neuron 33:751–763
Lee JI, Dhakal BK, Lee J, Bandyopadhyay J, Jeong SY, Eom SH, Kim DH, Ahnn J (2003) The Caenorhabditis elegans homologue of Down syndrome critical region 1, RCN-1, inhibits multiple functions of the phosphatase calcineurin. J Mol Biol 328:147–156
Lee JI, Mukherjee S, Yoon KH, Dwivedi M, Bandyopadhyay J (2013) The multiple faces of calcineurin signaling in Caenorhabditis elegans: development, behaviour and aging. J Biosci 38:1–15
Mair W, Morantte I, Rodrigues A, Manning G, Montminy M, Shaw RJ, Dillin A (2011) Lifespan extension induces by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature 470:404–408
Miyazaki T (2013) The role of taurine on skeletal muscle cell differentiation. Taurine 8. Springer 2:321–328
Palackal T, Moretz R, Wisniewski H, Sturman J (1986) Abnormal visual cortex development in the kitten associated with maternal dietary taurine deprivation. J Neurosci Res 15:223–239
Patterson D (2009) Molecular genetics analysis of Down syndrome. Hum Genet 126:195–214
Semsarian C, Wu MJ, Ju YK, Marciniec T, Yeoh T, Allen DG, Harvey RP, Graham RM (1999) Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature 400:576–581
Stewart AA, Ingebritsen TS, Manalan A, Klee CB, Cohen P (1982) Discovery of Ca2+ and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80). FEBS Lett 137:80–84
Strippoli P, Lenzi L, Petrini M, Carinci P, Zannotti M (2000) A new gene family including DSCR1 (Down syndrome candidate region 1) and ZAKI-4: Characterization from yeast to human and identification of DSCR-1like 2, a novel human member (DSCR1L2). Genomics 64:252–263
Vitvitsky V, Garg SK, Banerjee R (2011) Taurine biosynthesis by neurons and astrocytes. J Biol Chem 286:32002–32010
Whittle N, Sartori SB, Dlerssen M, Lubec G, Singewald N (2007) Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics 120:e1465–e1471
Yamori Y, Taguchi T, Hamada A, Kunimasa K, Mori H, Mori M (2010) Tuarine in health and disease: consistent evidence from experimental and epidemiological studies. J Biomed Sci 17:S6
Yang X, Zhang Z, Feng Y, Ren J, Liu F, Zu T (2012) Effect of taurine on lifespan and antioxidant in Drosophila. In: International conference on biomedical engineering and biotechnology, IEEE, pp 206–209
Acknowledgements
This work was supported by the 2015 University of Seoul Faculty Grant to DH Lee. The authors appreciate for the financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media B.V.
About this paper
Cite this paper
Ko, Y.J., Chang, H., Lee, D.H. (2017). Analysis of Taurine’s Anti-Down Syndrome Potential in Caenorhabditis elegans. In: Lee, DH., Schaffer, S.W., Park, E., Kim, H.W. (eds) Taurine 10. Advances in Experimental Medicine and Biology, vol 975. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-1079-2_89
Download citation
DOI: https://doi.org/10.1007/978-94-024-1079-2_89
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-024-1077-8
Online ISBN: 978-94-024-1079-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)